Truist Securities Reiterates Buy on Edwards Lifesciences, Raises Price Target to $118
Benzinga Newsdesk 10 hours ago
Analyst RatingsNewsReiterationPrice TargetHot
Truist Securities analyst Richard Newitter reiterates Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $113 to $118.
Truist Securities analyst Richard Newitter reiterates Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $113 to $118.